Clinical Features of COVID-19 Patients at Udayana University Hospital During First Three Months of the COVID-19 Pandemic
Abstract
COVID-19 exhibits a wide variety of symptoms, ranging from mild, moderate, severe, and critical respiratory dysfunctions up to death. Therefore, this study aimed to examine the demographic, clinical, and laboratory profile of COVID-19 patients admitted to Udayana University Hospital, Bali, during the first three months of the pandemic. Data were collected from the electronic medical records of 236 patients hospitalized from April to June 2020. The samples had a mean age of 40 years old, and they consisted of 58.50% male. Based on the records, the common clinical characteristics included fever (52.5%) and cough (47.5%), followed by less common traits, such as sore throat (18.2%), dyspnea (10.2%), flu (8.9%), and headache (3.8%). Laboratory results during admission showed an average lymphocyte count of 2.16 ± 2.19 × 109 cells/L and a neutrophil- lymphocyte ratio of 3.02 ± 3.41. The majority of patients were private corporation employees (30.51%), followed by migrant workers (21.19%). Furthermore, a fatality rate of 1.69% was recorded in the study hospital. These results were expected to provide epidemiological knowledge of COVID-19 patients, which can help clinicians to anticipate possible outcomes during treatment.
References
1. Wilder-Smith A, Freedman DO. Isolation, quarantine, social distancing and com-munity containment: Pivotal role for old-style public health measures in the novel coronavirus (2019-nCoV) outbreak. J Travel Med. 2020;27(2):1–4. https://doi.org/10.1093/jtm/taaa020
2. Andriani H. Effectiveness of Large-Scale Social Restrictions (PSBB) toward the New Normal Era during COVID-19 Out-break: a Mini Policy Review. J Indones Heal Policy Adm. 2020;5(2):61–5. http://dx.doi.org/10.7454/ihpa.v5i2.4001
3. Covid-19 - Indonesia: Puncak gelombang pertama “yang tak berujung”, mengapa protokol kesehatan sulit dipatuhi? - BBC News Indonesia [Internet]. [cited 2021 Apr 6].
4. Papoutsi E, Giannakoulis VG, Ntella V, Pappa S, Katsaounou P. Global burden of COVID-19 pandemic on healthcare workers. ERJ Open Res [Internet]. 2020 Apr 1 [cited 2021 Apr 6];6(2):00195–2020. Available from: https://doi.org/10.1183/23120541.00195-2020
5. Centers for Disease Control and Preven-tion. Principles of Epidemiology | Lesson 1 - Section 11 [Internet]. [cited 2021 Jun 26].
6. WHO Indonesia. Media Statement: Know-ing the risks for COVID-19. World Health Organization. 2020.
7. Setiati S, Azwar MK. COVID-19 and Indo-nesia. 2020;(April).
8. WHO Team. Coronavirus disease (COVID-19): How is it transmitted? World Health Organization. 2020.
9. Logie CH, Turan JM. How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research. AIDS Be-hav. 2020;24(7):2003–2006.
10. Rakesh S, and Madhusudan S. COVID-19 and Stigma: Social Discrimination Towards Frontline Healthcare Providers and COVID- 19 Recovered Patients in Nepal. Asian Journal of Psychiatry. 2020. https://pubmed.ncbi.nlm.nih.gov/3257009 6/
11. NCIRD Division of Viral Diseases. Symp-toms of Coronavirus. Centers for Disease Control and Prevention. 2020.
12. Khafaie MA, Rahim F. Osong Public Health and Research Perspectives Cross-Country Comparison of Case Fatality Rates of. Osong Public Heal Res Perspect. 2020;11(2):74–80. 10.24171/j.phrp.2020.11.2.03
13. Fanelli D, Piazza F. Since January 2020 Elsevier has created a COVID-19 re-source centre with free information in English and Mandarin on the novel coro-navirus COVID- 19 . The COVID-19 re-source centre is hosted on Elsevier Con-nect , the company ’ s public news and in-formation . 2020;(January).
14. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associat-ed with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032–1038. 10.1097/CM9.0000000000000775.
15. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):1–9. 10.1002/dmrr.3319
16. Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020;33(5):373–374. 10.1093/ajh/hpaa057
2. Andriani H. Effectiveness of Large-Scale Social Restrictions (PSBB) toward the New Normal Era during COVID-19 Out-break: a Mini Policy Review. J Indones Heal Policy Adm. 2020;5(2):61–5. http://dx.doi.org/10.7454/ihpa.v5i2.4001
3. Covid-19 - Indonesia: Puncak gelombang pertama “yang tak berujung”, mengapa protokol kesehatan sulit dipatuhi? - BBC News Indonesia [Internet]. [cited 2021 Apr 6].
4. Papoutsi E, Giannakoulis VG, Ntella V, Pappa S, Katsaounou P. Global burden of COVID-19 pandemic on healthcare workers. ERJ Open Res [Internet]. 2020 Apr 1 [cited 2021 Apr 6];6(2):00195–2020. Available from: https://doi.org/10.1183/23120541.00195-2020
5. Centers for Disease Control and Preven-tion. Principles of Epidemiology | Lesson 1 - Section 11 [Internet]. [cited 2021 Jun 26].
6. WHO Indonesia. Media Statement: Know-ing the risks for COVID-19. World Health Organization. 2020.
7. Setiati S, Azwar MK. COVID-19 and Indo-nesia. 2020;(April).
8. WHO Team. Coronavirus disease (COVID-19): How is it transmitted? World Health Organization. 2020.
9. Logie CH, Turan JM. How Do We Balance Tensions Between COVID-19 Public Health Responses and Stigma Mitigation? Learning from HIV Research. AIDS Be-hav. 2020;24(7):2003–2006.
10. Rakesh S, and Madhusudan S. COVID-19 and Stigma: Social Discrimination Towards Frontline Healthcare Providers and COVID- 19 Recovered Patients in Nepal. Asian Journal of Psychiatry. 2020. https://pubmed.ncbi.nlm.nih.gov/3257009 6/
11. NCIRD Division of Viral Diseases. Symp-toms of Coronavirus. Centers for Disease Control and Prevention. 2020.
12. Khafaie MA, Rahim F. Osong Public Health and Research Perspectives Cross-Country Comparison of Case Fatality Rates of. Osong Public Heal Res Perspect. 2020;11(2):74–80. 10.24171/j.phrp.2020.11.2.03
13. Fanelli D, Piazza F. Since January 2020 Elsevier has created a COVID-19 re-source centre with free information in English and Mandarin on the novel coro-navirus COVID- 19 . The COVID-19 re-source centre is hosted on Elsevier Con-nect , the company ’ s public news and in-formation . 2020;(January).
14. Liu W, Tao ZW, Wang L, Yuan ML, Liu K, Zhou L, et al. Analysis of factors associat-ed with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chin Med J (Engl). 2020;133(9):1032–1038. 10.1097/CM9.0000000000000775.
15. Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C, et al. Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev. 2020;36(7):1–9. 10.1002/dmrr.3319
16. Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. Am J Hypertens. 2020;33(5):373–374. 10.1093/ajh/hpaa057
Authors
Purnamasidhi, C. A. W., Sukmawati, N. M. D. D., Gayatri, A. A. A. Y., Utama, I. M. S., Somia, I. K. A., Merati, K. T. P., & Akatsu, H. (2022). Clinical Features of COVID-19 Patients at Udayana University Hospital During First Three Months of the COVID-19 Pandemic. Media Kesehatan Masyarakat Indonesia, 18(4), 147-152. https://doi.org/10.30597/mkmi.v18i4.20235
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.